[Diabetic edematous maculopathy associated with rosiglitazone treatment: report of a case].
A 61-year-old woman is referred for bilateral diabetic macular edema. Her visual acuity is 20/70 in the right eye and 20/50 in the left eye. She presents a macular edema on both eyes. Her diabetes and her blood pressure are well controlled. We note that the decrease in visual acuity occured when the patient began taking rosiglitazone (Avandia) 4 mg per day. Three months after replacing rosiglitazone by gliclazide (Diamicron), the visual acuity of the patient improves to 20/40 in the right eye and 20/30 in the left eye.
Nyssen
V
V
Cliniques Universitaires Saint Luc, UCL, Brussels. valentinenyssen@yahoo.fr
Hautenauven
F
F
Lekeu Hinostroza
J P
JP
Guagnini
A P
AP
D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000139:chemically induced* / Q000150:complications; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008269:Macular Edema / Q000139:chemically induced* / Q000150:complications; D008875:Middle Aged; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone